The Joint Corp. (JYNT)
USD 10.08
(0.6%)
USD 10.08
(0.6%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.07 Million USD | -80.69% |
| 2022 | 2.89 Million USD | -51.78% |
| 2021 | 6 Million USD | 9.4% |
| 2020 | 5.49 Million USD | 60.84% |
| 2019 | 3.41 Million USD | 1564.75% |
| 2018 | 205.11 Thousand USD | 106.46% |
| 2017 | -3.17 Million USD | 78.87% |
| 2016 | -15.02 Million USD | -61.25% |
| 2015 | -9.31 Million USD | -472.72% |
| 2014 | -1.62 Million USD | -469.88% |
| 2013 | 439.78 Thousand USD | 132.65% |
| 2012 | -1.34 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.58 Million USD | -209.06% |
| 2024 Q1 | 1.45 Million USD | 5.98% |
| 2023 FY | 559.52 Thousand USD | -80.69% |
| 2023 Q3 | -898.04 Thousand USD | -139.76% |
| 2023 Q4 | 1.37 Million USD | 252.61% |
| 2023 Q1 | -547.29 Thousand USD | -142.77% |
| 2023 Q2 | -374.55 Thousand USD | 31.56% |
| 2022 Q4 | 1.27 Million USD | 74.73% |
| 2022 Q1 | -162.61 Thousand USD | -124.52% |
| 2022 Q2 | 650.89 Thousand USD | 500.27% |
| 2022 Q3 | 732.31 Thousand USD | 12.51% |
| 2022 FY | 2.89 Million USD | -51.78% |
| 2021 Q1 | 1.97 Million USD | -28.94% |
| 2021 FY | 6 Million USD | 9.4% |
| 2021 Q2 | 2.03 Million USD | 3.18% |
| 2021 Q3 | 1.33 Million USD | -34.19% |
| 2021 Q4 | 663.21 Thousand USD | -50.47% |
| 2020 Q1 | 753.35 Thousand USD | -43.9% |
| 2020 Q2 | 258.58 Thousand USD | -65.68% |
| 2020 Q3 | 1.7 Million USD | 559.5% |
| 2020 FY | 5.49 Million USD | 60.84% |
| 2020 Q4 | 2.77 Million USD | 62.71% |
| 2019 Q4 | 1.34 Million USD | 109.72% |
| 2019 Q2 | 487.6 Thousand USD | -53.51% |
| 2019 Q1 | 1.04 Million USD | 12.07% |
| 2019 FY | 3.41 Million USD | 1564.75% |
| 2019 Q3 | 640.37 Thousand USD | 31.33% |
| 2018 Q3 | -191.3 Thousand USD | -90.54% |
| 2018 FY | 205.11 Thousand USD | 106.46% |
| 2018 Q4 | 935.88 Thousand USD | 589.22% |
| 2018 Q2 | -100.4 Thousand USD | 77.13% |
| 2018 Q1 | -439.06 Thousand USD | -94.51% |
| 2017 Q1 | -1.58 Million USD | 72.31% |
| 2017 FY | -3.17 Million USD | 78.87% |
| 2017 Q4 | -225.72 Thousand USD | 40.22% |
| 2017 Q3 | -377.63 Thousand USD | 61.64% |
| 2017 Q2 | -984.54 Thousand USD | 37.96% |
| 2016 Q1 | -3.48 Million USD | 0.53% |
| 2016 FY | -15.02 Million USD | -61.25% |
| 2016 Q4 | -5.73 Million USD | -119.22% |
| 2016 Q3 | -2.61 Million USD | 18.07% |
| 2016 Q2 | -3.19 Million USD | 8.45% |
| 2015 Q1 | -1.91 Million USD | -104.51% |
| 2015 Q3 | -2.05 Million USD | -11.1% |
| 2015 Q2 | -1.84 Million USD | 3.61% |
| 2015 Q4 | -3.5 Million USD | -70.86% |
| 2015 FY | -9.31 Million USD | -472.72% |
| 2014 FY | -1.62 Million USD | -469.88% |
| 2014 Q1 | -157.38 Thousand USD | -211.33% |
| 2014 Q4 | -936.51 Thousand USD | -201.3% |
| 2014 Q2 | -209.15 Thousand USD | -32.89% |
| 2014 Q3 | -310.82 Thousand USD | -48.61% |
| 2013 Q3 | 193.73 Thousand USD | 0.0% |
| 2013 Q4 | 141.36 Thousand USD | -27.03% |
| 2013 FY | 439.78 Thousand USD | 132.65% |
| 2012 FY | -1.34 Million USD | 0.0% |
| 2001 Q3 | 1.33 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 100.409% |
| Addus HomeCare Corporation | 90.95 Million USD | 102.279% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 121.861% |
| Amedisys, Inc. | 156.39 Million USD | 101.326% |
| American Oncology Network, Inc. | -49.15 Million USD | 95.782% |
| Astrana Health, Inc. | 84.61 Million USD | 102.45% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 125.682% |
| IMAC Holdings, Inc. | -6.37 Million USD | 67.484% |
| biote Corp. | 28.65 Million USD | 107.234% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 83.151% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 101.839% |
| COMPASS Pathways plc | -136.91 Million USD | 98.486% |
| DocGo Inc. | 15.05 Million USD | 113.77% |
| The Ensign Group, Inc. | 255.36 Million USD | 100.812% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 103.324% |
| InnovAge Holding Corp. | -23.18 Million USD | 91.057% |
| Assure Holdings Corp. | -20.08 Million USD | 89.677% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 98.904% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 86.799% |
| ModivCare Inc. | -139.94 Million USD | 98.519% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 5007.644% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 75.762% |
| Option Care Health, Inc. | 314.59 Million USD | 100.659% |
| P3 Health Partners Inc. | -167.86 Million USD | 98.765% |
| P3 Health Partners Inc. | -167.86 Million USD | 98.765% |
| The Pennant Group, Inc. | 25.16 Million USD | 108.237% |
| Surgery Partners, Inc. | 328 Million USD | 100.632% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 28.207% |
| Talkspace, Inc. | -23.2 Million USD | 91.068% |
| Talkspace, Inc. | -23.2 Million USD | 91.068% |
| The Oncology Institute, Inc. | -77.01 Million USD | 97.308% |
| The Oncology Institute, Inc. | -77.01 Million USD | 97.308% |